Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mycophenolate Mofetil vs Cyclosporine A for Moderate-Severe Psoriasis
NCT00295425Phase 2Unknown
- Sponsor
- Universitätsklinikum Münster
- Start
- May 2000
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of mycophenolate mofetil in psoriasis (2 arms), sponsored by Universitätsklinikum Münster. Primary endpoint: Time until psoriasis recurrence. Status: unknown.
02
Drugs
mycophenolate mofetil
03
Conditions
psoriasis
Beyond the preview
Go deeper on NCT00295425.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00295425.